相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100
Rosie Z. Yu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Lack of Pharmacokinetic Interaction of Mipomersen Sodium (ISIS 301012), a 2 '-O-Methoxyethyl Modified Antisense Oligonucleotide Targeting Apolipoprotein B-100 Messenger RNA, with Simvastatin and Ezetimibe
Rosie Z. Yu et al.
CLINICAL PHARMACOKINETICS (2009)
Oral delivery of antisense oligonucleotides in man
Lloyd G. Tillman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc et al.
NATURE BIOTECHNOLOGY (2008)
Biodistribution of 68Ga-labeled LNA-DNA mixmer antisense oligonucleotides for rat Chromogranin-A
Gabor Lendvai et al.
OLIGONUCLEOTIDES (2008)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inhaled CD86 antisense oligonucleotide suppresses pulmonary inflammation and airway hyper-responsiveness in allergic mice
Jeffrey R. Crosby et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Anti-inflammatory activity of inhaled IL-4 receptor-α antisense oligonucleotide in mice
James G. Karras et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100
Rosie Z. Yu et al.
DRUG METABOLISM AND DISPOSITION (2007)
Inhibition of respiratory syncytial virus (RSV) replication in cell culture by small interfering RNA (siRNA)
M. R. Khaitov et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Nucleotide pyrophosphatase/phosphodiesterase 1 is responsible for degradation of antisense phosphorothioate oligonucleotides
Marzena Wojcik et al.
OLIGONUCLEOTIDES (2007)
Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B
John J. P. Kastelein et al.
CIRCULATION (2006)
Antisense oligonucleotide therapy for neurodegenerative disease
Richard A. Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse
Joseph Moore et al.
LEUKEMIA RESEARCH (2006)
Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis
PB Miner
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302)
Tanya A. Watanabe et al.
OLIGONUCLEOTIDES (2006)
Lack of pharmacokinetic interaction for ISIS 113715, a 2 '-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone
Richard S. Geary et al.
CLINICAL PHARMACOKINETICS (2006)
Central administration of small interfering RNAs in rats: A comparison with antisense oligonucleotides
C Senn et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers
A Amantana et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Spinal distribution and metabolism of 2 '-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats
M Butler et al.
NEUROSCIENCE (2005)
Biodistribution of phosphodiester and phosphorothioate siRNA
DA Braasch et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis
P Miner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Neutrally charged phosphorodiamidate morpholino antisense oligomers: Uptake, efficacy and pharmacokinetics
V Arora et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2004)
RNA interference and chemically modified small interfering RNAs
M Manoharan
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Tissue disposition of 2 '-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys
RZ Yu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents - A comparative analysis
TA Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2 '-O-(2-methoxyethyl) modified antisense oligonucleotide: Comparison across species
RS Geary et al.
DRUG METABOLISM AND DISPOSITION (2003)
Phase I trial of ISIS 104838, a 2′-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-α
KL Sewell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Bioavailability and efficacy of antisense morpholino oligomers targeted to c-myc and cytochrome P-450 3A2 following oral administration in rats
V Arora et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Fomivirsen - Clinical pharmacology and potential drug interactions
RS Geary et al.
CLINICAL PHARMACOKINETICS (2002)
Hepatic distribution of a phosphorothioate oligodeoxynucleotide within rodents following intravenous administration
MJ Graham et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Absorption, distribution, metabolism, and excretion of a respirable antisense oligonucleotide for asthma
S Ali et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotide following inhalation delivery to lung in mice
MV Templin et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2000)
Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis
H Zhang et al.
NATURE BIOTECHNOLOGY (2000)
Absorption of antisense oligonucleotides in rat intestine: Effect of chemistry and length
O Khatsenko et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2000)
Nucleocytoplasmic shuttling:: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides
P Lorenz et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
